JP4456754B2 - 疼痛管理のための新規な使用 - Google Patents

疼痛管理のための新規な使用 Download PDF

Info

Publication number
JP4456754B2
JP4456754B2 JP2000528283A JP2000528283A JP4456754B2 JP 4456754 B2 JP4456754 B2 JP 4456754B2 JP 2000528283 A JP2000528283 A JP 2000528283A JP 2000528283 A JP2000528283 A JP 2000528283A JP 4456754 B2 JP4456754 B2 JP 4456754B2
Authority
JP
Japan
Prior art keywords
pain
ropivacaine
point
preparation according
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000528283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002501021A5 (https=
JP2002501021A (ja
Inventor
イェラン・イーサークソン
ダーグ・セランデール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of JP2002501021A publication Critical patent/JP2002501021A/ja
Publication of JP2002501021A5 publication Critical patent/JP2002501021A5/ja
Application granted granted Critical
Publication of JP4456754B2 publication Critical patent/JP4456754B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Adornments (AREA)
JP2000528283A 1998-01-21 1999-01-11 疼痛管理のための新規な使用 Expired - Lifetime JP4456754B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9800139-9 1998-01-21
SE9800139A SE9800139D0 (sv) 1998-01-21 1998-01-21 New use
PCT/SE1999/000012 WO1999037301A1 (en) 1998-01-21 1999-01-11 New use for pain management

Publications (3)

Publication Number Publication Date
JP2002501021A JP2002501021A (ja) 2002-01-15
JP2002501021A5 JP2002501021A5 (https=) 2006-03-02
JP4456754B2 true JP4456754B2 (ja) 2010-04-28

Family

ID=20409917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000528283A Expired - Lifetime JP4456754B2 (ja) 1998-01-21 1999-01-11 疼痛管理のための新規な使用

Country Status (11)

Country Link
US (2) US6395291B1 (https=)
EP (1) EP1054671B1 (https=)
JP (1) JP4456754B2 (https=)
AT (1) ATE228840T1 (https=)
AU (1) AU2444399A (https=)
DE (1) DE69904297T2 (https=)
DK (1) DK1054671T3 (https=)
ES (1) ES2189386T3 (https=)
PT (1) PT1054671E (https=)
SE (1) SE9800139D0 (https=)
WO (1) WO1999037301A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200611217A (en) * 2005-12-06 2006-04-01 Shin Hwa Biotech Co Ltd Human model for indexing nerve paths (locus) having corresponding relations and method for indexing
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US10111850B2 (en) * 2015-12-01 2018-10-30 Samuel Wilson Ester and cholinesterase inhibitor in long-acting nerve block
CA2898933A1 (en) * 2014-07-30 2016-01-30 Grigory Karmy Method for relieving chronic pain
US10751249B2 (en) * 2017-11-26 2020-08-25 Johnson Athletic Advantage LLC Trigger point dry needling in motion and method of use
BE1026845B1 (nl) 2018-12-07 2020-07-08 Fagron Compounding Services Nv Samenstelling voor gebruik in lokale infiltratie analgesie (LIA)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (en) 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE451840B (sv) 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
SE9401174D0 (sv) 1994-04-07 1994-04-07 Astra Ab New combination
ATE219674T1 (de) 1997-03-13 2002-07-15 James N Campbell Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika

Also Published As

Publication number Publication date
EP1054671B1 (en) 2002-12-04
DK1054671T3 (da) 2003-02-24
WO1999037301A1 (en) 1999-07-29
ATE228840T1 (de) 2002-12-15
US6395291B1 (en) 2002-05-28
PT1054671E (pt) 2003-03-31
US6620423B2 (en) 2003-09-16
EP1054671A1 (en) 2000-11-29
US20020156101A1 (en) 2002-10-24
DE69904297T2 (de) 2003-08-21
SE9800139D0 (sv) 1998-01-21
AU2444399A (en) 1999-08-09
JP2002501021A (ja) 2002-01-15
ES2189386T3 (es) 2003-07-01
DE69904297D1 (de) 2003-01-16

Similar Documents

Publication Publication Date Title
Grushka et al. Burning mouth syndrome
Moore et al. The anesthetic efficacy of 4 percent articaine 1: 200,000 epinephrine: two controlled clinical trials
Poellmann et al. Current management of pain associated with multiple sclerosis
Hersh et al. The pharmacokinetics and cardiovascular effects of high-dose articaine with 1: 100,000 and 1: 200,000 epinephrine
Gawin et al. Outpatient treatment of'crack'cocaine smoking with flupenthixol decanoate: a preliminary report
Majid Submucosal dexamethasone injection improves quality of life measures after third molar surgery: a comparative study
Othman et al. Non‐opioid drugs for pain management in labour
Baad-Hansen et al. Differential effect of intravenous S-ketamine and fentanyl on atypical odontalgia and capsaicin-evoked pain
Ernberg et al. Ropivacaine for dental anesthesia: a dose-finding study
Giannakopoulos et al. The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline: preliminary findings
Platon et al. Effects of high-frequency, high-intensity transcutaneous electrical nerve stimulation versus intravenous opioids for pain relief after gynecologic laparoscopic surgery: a randomized controlled study
JP4456754B2 (ja) 疼痛管理のための新規な使用
KR20170120708A (ko) 탈수초를 갖는 환자에서 ４-아미노피리딘을 사용한 지속적 치료
Gupta et al. Comparative evaluation of efficacy of EMLA and needleless jet anesthesia in non-surgical periodontal therapy
Conforti et al. Intradermal therapy (mesotherapy) for the treatment of acute pain in carpal tunnel syndrome: a preliminary study.
Scott et al. The efficacy of a repeated infiltration in prolonging duration of pulpal anesthesia in maxillary lateral incisors
Gupta et al. A comparative study of trigger point therapy with local anaesthetic (0.5% bupivacaine) versus combined trigger point injection therapy and levosulpiride in the management of myofascial pain syndrome in the orofacial region
Vaiman et al. Oxycodone and dexamethasone for pain management after tonsillectomy: a placebo-controlled EMG assessed clinical trial
Hosny et al. Anesthetic efficacy of 4% artpharmadent versus 2% mepecaine-l for infiltration anesthesia in extraction of badly decayed lower first primary molars: a pilot study
Sabatke et al. Trigger point infiltrations into the temporal muscles of patients with fibromyalgia and headaches: a randomized, double-blinded and controlled study
Khidr et al. Tempro Mandibular Joint Internal Derangement: A Comparative Analysis of Ozone Gas and Ozonated Water Following Arthrocentesis
Joshi et al. Comparative evaluation of pricking pain response, behavioural response, heart rate and blood pressure response to prilido cream and lignocad gel prior to local anesthesia administration in children
SINGH et al. Efficacy of Magnesium Sulfate and Dexmedetomidine as Adjuvants to Ropivacaine in Supraclavicular Brachial Plexus Block: A Randomised Clinical Study.
Debnath et al. Efficacy of Ultrasound-guided Autologous Blood Injection in Chronic Lateral Epicondylitis: A Randomized Controlled Trial
Habaka et al. Comparative study between Sodium hyaluronic acid and dextrose prolotherapy in management of Temporo-mandibular joint internal derangement.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060106

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090915

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091211

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20091211

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100126

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100208

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130212

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130212

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140212

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term